يعرض 1 - 10 نتائج من 58 نتيجة بحث عن '"Mesothelioma / pathology"', وقت الاستعلام: 0.94s تنقيح النتائج
  1. 1
  2. 2

    المصدر: Louw, A, Panou, V, Szejniuk, W M, Meristoudis, C, Chai, S M, van Vliet, C, Lee, Y C G, Dick, I M, Firth, T, Lynggaard, L A, Asghari, A B, Vyberg, M, Hansen, J, Creaney, J & Røe, O D 2022, ' BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma : A validation study ', Journal of Thoracic Oncology, vol. 17, no. 7, pp. 921-930 . https://doi.org/10.1016/j.jtho.2022.04.008

    وصف الملف: application/pdf

  3. 3
    كتاب

    المساهمون: Galateau-Sallé, Françoise.

  4. 4
    كتاب

    المساهمون: Pass, Harvey I., Vogelzang, Nicholas., Carbone, Michele., Carbone, Michele, 1960-

  5. 5

    المساهمون: University of Zurich, Pulmonary Medicine, Pathology

    المصدر: Modern Pathology, 35(12), 1888-1899. SPRINGERNATURE
    Modern Pathology, 35(12), 1888-1899. Nature Publishing Group

    وصف الملف: application/pdf; Print-Electronic; Ruschoff_ModPath_2022.pdf - application/pdf

  6. 6
  7. 7

    المصدر: Mark, M; Rusakiewicz, S; Früh, M; Hayoz, S; Grosso, F; Pless, M; Zucali, P; Ceresoli, G L; Maconi, A; Schneider, M; Froesch, P; Tarussio, D; Benedetti, F; Dagher, J; Kandalaft, L; von Moos, R; Tissot-Renaud, S; Schmid, S; Metaxas, Y (2022). Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study. ESMO open, 7(3), p. 100446. BMJ 10.1016/j.esmoop.2022.100446 <http://dx.doi.org/10.1016/j.esmoop.2022.100446>
    ESMO open, vol. 7, no. 3, pp. 100446

    وصف الملف: application/pdf

  8. 8
  9. 9
    كتاب

    المؤلفون: Battifora, Hector.

    المساهمون: McCaughey, W. T. Elliott., Armed Forces Institute of Pathology (U.S.), Universities Associated for Research and Education in Pathology.

  10. 10